This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by McKenzie, P. T. Articles by Sugarman, J. R. Search for Related Content PubMed PubMed Citation Articles by McKenzie, P. T. Articles by Sugarman, J. R. Social Bookmarking                         What's this?

Implications for Clinical Performance Measurement of Interlaboratory Variability in Methods for Glycosylated Hemoglobin Testing

Department of Family Medicine, University of Washington, Seattle

Jonathan R. Sugarman, MD, MPH

Departments of Epidemiology and Family Medicine, University of Washington, Seattle, PRO-West, Seattle, Wash. wapro.jsugarma{at}sdps.org

In order to evaluate interlaboratory variation in glycosylated hemoglobin (GHb) testing in the context of quality assessment and performance measurement systems, we conducted a telephone survey of laboratories in Washington state. The survey focused on GHb testing methods, analytes measured, reference ranges, awareness of and adherence to the National Glycohemoglobin Standardization Program (NGSP) standards, and recent changes in methods. We contacted 30 (81%) of 37 laboratories known to conduct GHb testing. Among the 25 laboratories using 1 or more test methods in-house, 5 (20%) reported only total GHb levels rather than HbA_1C. There was considerable variability in test methods used and in reported high and low reference ranges within and across methods. Eight (30%) of 27 individual methods used by the laboratories were not certified by the NGSP. From January 1997 through August 1998, 11 of 25 laboratories (44%) made changes in testing methods. Despite national efforts to decrease variability in GHb testing methods, substantial variability remained in Washington state in 1997. In addition to hindering management of individual patients, this variability poses challenges for clinical performance measurement systems such as the Health Plan and Employer Data Information Set that attempt to compare the adequacy of glycemic control among health systems. However, the high frequency of recent changes in testing methods may indicate an improving trend in test methods.

Key Words: Diabetes mellitus • glycated hemoglobin • laboratory methods • performance measurement

American Journal of Medical Quality, Vol. 15, No. 2, 62-64 (2000)
DOI: 10.1177/106286060001500204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Kleerekoper Biochemical Markers of Bone Turnover: Why Theory, Research, and Clinical Practice Are Still in Conflict Clin. Chem., August 1, 2001; 47(8): 1347 - 1349. [Full Text] [PDF]

				K. L. Stoner, N. J. Lasar, M. K. Butcher, L. M. Fawcett, M. E. Danelson, T. S. Harwell, and S. D. Helgerson Improving Glycemic Control: Can Techniques Used in a Managed Care Setting Be Successfully Adapted to a Rural Fee-for-Service Practice? American Journal of Medical Quality, May 1, 2001; 16(3): 93 - 98. [Abstract] [PDF]

				C. L. Marshall Letter to the Editor American Journal of Medical Quality, September 1, 2000; 15(5): 196 - 196. [PDF]

				J. Counts, M. Marcus-Smith, J. Norman, and J. Sugarman Letter to the Editor American Journal of Medical Quality, May 1, 2000; 15(3): 123 - 123. [PDF]